Social
Take a look at our COVID-19 section of the site to see all articles published on this virus.
https://t.co/TiB7739ONL
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 11 months ago
Dr. J Curtis discussing ACR’s COVID Vaccine guidance.
Testing for antibodies may not be necessary at this time as common lab tests differ in what they target. #RNL2021 https://t.co/Xd0DYiwZEg
Robert B Chao, MD @doctorRBC ( View Tweet )
3 years 11 months ago
News Feature: New Side Effect From mRNA COVID Vaccines?
Herpes zoster reactivation following COVID-19 vaccination in 6 patients with comorbid autoimmune/inflammatory diseases may be a new adverse event associated with the Pfizer/BioNTech mRNA vaccine.
https://t.co/GgjoIpYDkC https://t.co/sI2Fx0o05G
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 11 months ago
News Feature: Planes, Trains and COVID Distancing
MMWR reports the risk of acquiring an infection with SARS-CoV-2 is reduced 23% to 57% when the middle seat was vacant (compared with full aircraft occupancy).
https://t.co/tGs9GopeGu https://t.co/ZRMltTpYgW
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years ago
Study of 26 patients with chronic inflammatory cdiseases vaccinated with mRNA vaccines showed all with considerable immunogenic responses. No unexpected side effects seen and No flares of the underlying inflammatory disease was seen. https://t.co/7Q5bYp5A9i
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years ago
HLA-B27 status does not change the risk of COVID-19 in spondyloarthritis patients. Survey of 3435 SpA pts; shows 76% as HLA-B27 positive. COVID infx was thesame between B27 Pos & Neg pts (1.5% vs 1.4%) and severity was also the same https://t.co/qavodFynr0
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years ago
#RNL2021 Coverage from @KDAO2011
"Psoriatic Arthritis Pearls by Dr. E Ruderman
-MTX monoRx is effective
-which TNFi does not matter
-Secukinumab 300 mg is better than 150 mg dose
-OK to use IL-17i in pts with FHx of IBD"
#RheumNow
Dr. John Cush @RheumNow ( View Tweet )
4 years ago
CDC updates its COVID Comorbid Dz list to include type 1 diabetes (& NIDDMA), mod-severe asthma, liver Dz, dementia , stroke/cerebrovascular disease, HIV infxn, cystic fibrosis, obesity, substance use disorders (NOT ARTHRITIS, PSORIASIS) https://t.co/LbVMVGf4IR
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years ago
Survey of 500 pts with systemic rheumatic diseases during the COVID-19 pandemic showed few who discontinuations Rx - 2.2% D/C for fear of immunosuppression; 3.8% for shortages (mostly HCQ); 2.6%) for resp infx and 6% for side-effects. https://t.co/2BJIYeBSIu
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years ago
Hydroxychloroquine studied vs Vitamin C (PBO) prophylaxis to households (n=671) exposed to COVID-19. 89% were COVD1-9 test neg at baseline. HCQ did not protect against progression to COVID (53 vs 45 events; adj HR, 1.10 [95% CI, 0.73 to 1.66]. A vit C Win! https://t.co/S5qjdIYaXq
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 1 month ago
